Nov 22, 2021 / 01:00PM GMT
Operator
Dear ladies and gentlemen, welcome to the Merck R&D Update Call. (Operator Instructions) May I now hand you over to Constantin Fest, Head of Investor Relations, who will lead you through this conference. Please go ahead, sir.
Constantin Fest - MERCK Kommanditgesellschaft auf Aktien - Head of IR
Thank you, Alan. Dear ladies and gentlemen, a very warm welcome to this 2021 Merck R&D Update Call. My name is Constantin Fest, and I'm Head of Investor Relations here at Merck. I'm delighted also to have with me here today, Danny Bar-Zohar, Head of Development; Joern-Peter Halle, Head of Research; as well as Andrew Paterson, Chief Marketing Officer.
For the Q&A part of this call, we will also be joined by Andree Blaukat, Head of Research Oncology, Amy Kao, Head of Research Immunology; Jan Klatt, Head of Development Neurology & Immunology; as well as Victoria Zazulina, Head of Development Oncology.
We will now guide you through the key slides of this presentation. This will be then followed by a Q&A for you to ask all your questions.
Merck KGaA R&D Update Call Transcript
Nov 22, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers